5 Key Takeaways

• 1

  A smartphone-based AI platform named CaptureTumor (CaT) aims to improve early detection of ocular surface malignancies.

• 2

  The system utilizes smartphone photography and automated image analysis to classify lesions as benign or malignant.

• 3

  In a clinical trial, the app achieved an AUC of 0.977, with sensitivity of 89.3% and specificity of 95.9% in real-world screening.

• 4

  The platform identified 20 confirmed malignancies, with 19 cases being previously undiagnosed, suggesting earlier detection.

• 5

  The study demonstrates the potential of consumer technologies in enhancing public health and access to specialist eye care.